Cover Image
Market Research Report

Global Permanent Artificial Skin Market 2019-2023

Published by TechNavio (Infiniti Research Ltd.) Product code 781942
Published Content info 103 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Permanent Artificial Skin Market 2019-2023
Published: January 25, 2019 Content info: 103 Pages
Description

About this market

Increasing initiatives to raise awareness of skin and tissue donation to drive market growth. Organizations such as Donate Life America are conducting an increasing number of awareness programs to increase the awareness of skin ailments that require replacement surgeries and the need for skin donation. Donate Life America is a non-profit organization that promotes the donation of organs, eyes, and tissue. The organization partners with other organizations such as the American Association of Tissue Banks to educate the population across the US about tissue donation and encourage people to donate tissue. Technavio's analysts have predicted that the permanent artificial skin market will register a CAGR of almost 19% by 2023.

Market Overview

Availability of cost-effective treatment in developing countries

The global permanent artificial skin market is not regulated in developing countries in South America and APAC. The high availability of certified doctors and the low cost of treatment is driving the growth of permanent artificial skin market in these regions. Countries such as China, India, Brazil, and South Korea are among the top 10 countries in the world in terms of the number of certified cosmetic surgeons.

Lack of accessibility and affordability of diagnostic test centers

Advanced diagnostic centers that offer a wide range of diagnostic tests are widely present in developing countries. However, there is a shortage of such centers in developing countries, where the disease burden is high. As a result, numerous patients with chronic diseases remain undiagnosed due to the lack of availability of diagnostic centers.

For the detailed list of factors that will drive and challenge the growth of the permanent artificial skin market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including MiMedx and Solsys Medical the competitive environment is quite intense. Factors such as the increasing initiatives to raise awareness of skin and tissue donation and the expansion of aircraft manufacturing facilities, will provide considerable growth opportunities to permanent artificial skin manufactures. Avita Medical, EUCARE PHARMACEUTICALS, Integra LifeSciences, MiMedx, and Solsys Medical are some of the major companies covered in this report.

Table of Contents
Product Code: IRTNTR30746

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Hospitals - Market size and forecast 2018-2023
  • Other healthcare centers - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Technological advances
  • Strategic alliances
  • Increasing initiatives to raise awareness of skin and tissue donation

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Avita Medical
  • EUCARE PHARMACEUTICALS
  • Integra LifeSciences
  • MiMedx
  • Solsys Medical

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: End-user - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by end-user
  • Exhibit 19: Hospitals - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Hospitals - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Other healthcare centers - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Other healthcare centers - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Market opportunity by end-user
  • Exhibit 24: Customer landscape
  • Exhibit 25: Market share by geography 2018-2023 (%)
  • Exhibit 26: Geographic comparison
  • Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 29: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: APAC - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: APAC - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: Key leading countries
  • Exhibit 36: Market opportunity
  • Exhibit 37: Impact of drivers and challenges
  • Exhibit 38: Vendor landscape
  • Exhibit 39: Landscape disruption
  • Exhibit 40: Vendors covered
  • Exhibit 41: Vendor classification
  • Exhibit 42: Market positioning of vendors
  • Exhibit 43: Avita Medical - Vendor overview
  • Exhibit 44: Avita Medical - Business segments
  • Exhibit 45: Avita Medical - Organizational developments
  • Exhibit 46: Avita Medical - Geographic focus
  • Exhibit 47: Avita Medical - Key offerings
  • Exhibit 48: EUCARE PHARMACEUTICALS - Vendor overview
  • Exhibit 49: EUCARE PHARMACEUTICALS - Product segments
  • Exhibit 50: EUCARE PHARMACEUTICALS - Key offerings
  • Exhibit 51: Integra LifeSciences - Vendor overview
  • Exhibit 52: Integra LifeSciences - Business segments
  • Exhibit 53: Integra LifeSciences - Organizational developments
  • Exhibit 54: Integra LifeSciences - Geographic focus
  • Exhibit 55: Integra LifeSciences - Segment focus
  • Exhibit 56: Integra LifeSciences - Key offerings
  • Exhibit 57: MiMedx - Vendor overview
  • Exhibit 58: MiMedx - Business segments
  • Exhibit 59: MiMedx - Key offerings
  • Exhibit 60: Solsys Medical - Vendor overview
  • Exhibit 61: Solsys Medical - Business segments
  • Exhibit 62: Solsys Medical - Key offerings
  • Exhibit 63: Validation techniques employed for market sizing
Back to Top